Streetbeat News

Stock Prices

PBPB

Potbelly (NASDAQ:PBPB) reported Q4 earnings with a -33.0% miss on estimated EPS, achieving $0.02 versus the expected $0.03. Revenue increased by $5.60 million from the same period last year. In the previous quarter, Potbelly exceeded EPS estimates, leading to a 10.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:15 pm

COIN

Goldman Sachs analyst Will Nance upgraded Coinbase Global (NASDAQ:COIN) from Sell to Neutral and set a price target of $282.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:14 pm

MGNX

Macrogenics (NASDAQ:MGNX) reported a Q4 2023 GAAP EPS of $(0.750) and sales of $10.720M, marking an 85.33% decrease from $73.099M in sales YoY.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:14 pm

MDB

MongoDB shares are trading lower following the company's announcement of weak guidance for both Q1 and the full fiscal year 2025, indicating potential challenges ahead.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:11 pm

OWLT

Owlet (NYSE:OWLT) reported Q4 2023 adjusted EPS of $(0.120), missing the $(0.040) estimate, with sales of $21.000M also missing the $21.160M estimate. This represents a 75% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:11 pm

SWBI

Smith & Wesson Brands (SWBI) reported Q3 2024 adjusted EPS of $0.190, surpassing the $0.100 estimate, with sales of $137.500M exceeding the $133.548M forecast. This represents a 6.56% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:10 pm

ONCY

Oncolytics Biotech (NASDAQ:ONCY) reported Q4 earnings, beating estimates with an EPS of $-0.04 against an expected $-0.11, despite revenue being down from the previous year. The company's past earnings performance saw a miss on EPS last quarter, leading to a 4.0% share price drop the following day.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:10 pm

LUMO

Lumos Pharma (NASDAQ:LUMO) reported Q4 earnings with an EPS of $-1.17, missing estimates by -2.0%. Revenue increased by $314 thousand year-over-year. Despite missing this quarter's earnings estimates, past performance shows a positive trend in share price following earnings beats.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:10 pm

MSTR

TSLA

Arkham Intelligence reported an increase in Tesla's Bitcoin holdings, now totaling approximately 11,509 BTC, which is 1,789 BTC more than previously disclosed. Tesla, under Elon Musk, has had a fluctuating relationship with Bitcoin, including a significant purchase in 2021 and later sales. Neither Tesla nor Musk has commented on the recent speculation. SpaceX, also led by Musk, holds Bitcoin. MicroStrategy, a major institutional Bitcoin holder, and its co-founder Michael Saylor, have influenced corporate Bitcoin investment, with Saylor advocating for a bullish future for Bitcoin.

Portfolio Pulse from Murtuza Merchant

March 07, 2024 | 9:10 pm

MRVL

Marvell Technology, Inc. has announced a new stock repurchase program authorizing the buyback of up to $3 billion of its shares. This move is part of the company's strategy to return value to its shareholders and optimize its capital structure. The repurchase authorization does not have an expiration date and may be executed through open market purchases or privately negotiated transactions at the company's discretion.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:09 pm